Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine and platelet aggregation in splenectomized non–transfusion-dependent thalassemia
IRCT20100110003032N4Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetylcysteine in beta thalassemia, sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Platelet aggregation. Started Mar 2023; status: completed.
02
Drugs
acetylcysteine
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on IRCT20100110003032N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100110003032N4.